Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) trial
2017-000427-27Phase 2Completed
- Sponsor
- Capitol Region Blood Bank
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of octaplas lg in septic shock (2 arms), sponsored by Capitol Region Blood Bank. Primary endpoints: Efficacy of OctaplasLG compared to crystalloids in septic shock and Safety of OctaplasLG compared to crystalloids in septic shock. Started Feb 2017; status: completed.
02
Drugs
octaplas lg
03
Conditions
septic shock
Beyond the preview
Go deeper on 2017-000427-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000427-27.